MentionFox
Home › funding signals › BIOVIE INC.
Form D · on the record

BIOVIE INC. — Form D filing, November 2026

Before you sell to, join or invest in BIOVIE INC.

MentionFox check on BIOVIE INC.: only 1 source on file so far (checked 20 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/biovie-inc-form-d-000499

Check BIOVIE INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about BIOVIE INC.?

BIOVIE INC. filed a Form D with the Securities and Exchange Commission on 2026-11-19.

BIOVIE INC. filed a Form D notice of an exempt securities offering with the SEC on November 19, 2026. Its industry group is Biotechnology. It names Cuong Do (President and CEO), Joanne Kim (CFO), Sigmund Rogich (Director) (SEC Form D, November 19, 2026).

Sell to companies like BIOVIE INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

BIOVIE INC. raised on Nov 19. 137 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Linework USA INC.$1.2BAI and software
Linework USA INC.$326MAI and software
Pathos AI, Inc.$238MBiotech
Galvanize Therapeutics, Inc.$136MBiotech
Tractian Inc.$106MAI and software
Check one company free All companies that raised this week

1 more Biotechnology raise in Nevada within 90 days ↓

Selling to Biovie Inc.? See who runs it and how to reach them, plus this week's 161 other newly funded companies.

Is this your company?

Key facts

Run the free check on BIOVIE INC. →

BIOVIE INC.

New Form D on file · 2026-11-19 · the record

$0
raise on the record
D
filing
1
investors in
NEVADA
based
Open the record →

What the record says

FilingForm D
Filed2026-11-19
Industry groupBiotechnology
Entity typeCorporation
Incorporated inNEVADA
BasedCARSON CITY, NEVADA
CIK1580149
Accession0001520138-26-000499

Pitching, partnering or investing alongside them? See who really runs and owns BIOVIE INC.

Free to see. No signup.

Keep reading

More on the people and the money behind BIOVIE INC., from the filings we hold.

More raises like this

Biotechnology raises by companies based in Nevada, filed within 90 days of this one, largest first.

What do you want to do with BIOVIE INC.?

Get the full cited report on BIOVIE INC.

What the filing shows about BIOVIE INC.

  • 1 investor had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on BIOVIE INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look BIOVIE INC. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on BIOVIE INC.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives BIOVIE INC.'s address as 680 W. Nye Lane, Suite 201, Carson City, NV 89703.

What the filing says

  • Offered: $0. Sold: nothing yet. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: November 3, 2026. (filing)
  • Types of securities: Options, warrants or other rights to acquire another security; Securities to be acquired on exercise of an option, warrant or other right. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “The warrants were issued without additional consideration in connection with a registered offering of common stock at $1.60 per share and accompanying warrant. No separate consideration was paid.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on BIOVIE INC. See pricing

Is BIOVIE INC. a real, registered company?

BIOVIE INC. is a registered filer with the SEC (CIK 1580149) and has filed since 2026-11-19. 1 filing is on record, the latest on 2026-11-19.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs BIOVIE INC.?

BIOVIE INC.'s Form D of 2026-11-19 names Cuong Do, Joanne Kim, Sigmund Rogich and 4 more as its officers, directors or promoters.

Biotechnology · by week

Trailing twelve months. 760 filings in Biotechnology, totalled by week.

Want the whole picture on BIOVIE INC.?

What the filing shows about BIOVIE INC.

  • 1 investor had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on BIOVIE INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on BIOVIE INC. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for BIOVIE INC.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/biovie-inc-form-d-000499
Last updated 2026-11-20
Primary record: SEC filing 1 · SEC filing 2
BIOVIE INC. — SEC Form D filing, November 2026. MentionFox, 2026-11-20. https://mentionfox.com/funding/biovie-inc-form-d-000499